Clinical Trials
9 trialsNCT02633111 2025-11-04
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT02471911 2022-04-12
KPT-330+RICE
Weill Medical College of Cornell University
Phase 1 Completed
NCT00038545 2018-10-30
A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00233454 2018-09-20
Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia
Stanford University
Phase 2 Completed
NCT00201669 2017-12-06
A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT00718770 2014-01-17
A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression
University of Colorado, Denver
Phase EARLY_PHASE1 Completed
NCT01417442 2011-08-16
BRAF V600E Mutations In Papillary Thyroid Carcinoma
Bezmialem Vakif University
Phase EARLY_PHASE1 Unknown
NCT00410657 2010-05-14
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT00517894 2007-08-17
Dose-Dense Therapy in Aggressive Lymphoma
Arbeitsgemeinschaft medikamentoese Tumortherapie
No longer available